In terms of the prognostic value of EPCAM expression loss, we revealed that EPCAM-PL is significantly associated with poor DFS in CRC compared with EPCAM-intact (Figure 3B) and is proven to be an independent poor prognostic factor in CRC (Table 3). This evidence concerns the gene EPCAM and colorectal carcinoma.